Kan Chen

Kan Chen

Director/Board Member at INSILICO MEDICINE CAYMAN TOPCO
44 year
Health Technology
Consumer Services

Profile

Kan Chen is currently a Non-Executive Director at LongBio Pharma (Suzhou) Co., Ltd. since 2025, InSilico Medicine Cayman TopCo since 2023, and Ming Yu Pharmaceutical Ltd. since 2025.
Former roles include Director at Jiangsu Yahong Meditech Co., Ltd. from 2020 to 2023; Non-Executive Director at Antengene Corp.
Ltd. from 2021 to 2024; Non-Executive Director at Abbisko Cayman Ltd. from 2020 to 2021; Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2024; and Non-Executive Director at Connect Biopharma Holdings Ltd. from 2020 to 2025.
Education includes a doctorate from Case Western Reserve University conferred in 2009, an undergraduate degree from Fudan University conferred in 2004, and a doctorate from Harvard Medical School conferred in 2012.

Kan Chen active positions

CompaniesPositionStart
INSILICO MEDICINE CAYMAN TOPCO Director/Board Member 31/05/2023

Former positions of Kan Chen

CompaniesPositionEnd
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 30/11/2025
CANBRIDGE PHARMACEUTICALS INC. Director/Board Member 31/08/2024
ANTENGENE CORPORATION LIMITED Director/Board Member 31/05/2024
JIANGSU YAHONG MEDITECH CO., LTD. Director/Board Member 30/11/2023
ABBISKO CAYMAN LIMITED Director/Board Member 31/05/2021
See the detail of Kan Chen's experience

Training of Kan Chen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW